3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide

C172H239N33O15S4 — CID 54482666

IUPAC3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide
SMILESCCCCCCCCCCC(Oc1ccc(S(=O)(=O)c2ccc(O)cc2)cc1)C(=O)Nc1cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)c1.CCCCCCCCCCCCCCCCOc1ccc(C(C)(C)C)cc1OS(=O)Nc1cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)c1.CCCCCCCCCCCCCCCCOc1ccc(C(C)(C)C)cc1OS(=O)Nc1cc(NC(=O)C(C)(C)C)cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)c1.Cc1ccc(OCCCNS(=O)(=O)c2cc(-c3nc4cc(C(C)(C)C)[nH]n4n3)cc(-c3nc4cc(C(C)(C)C)[nH]n4n3)c2)c(C)c1
InChIInChI=1S/C48H71N9O3S.C46H57N9O5S.C45H70N6O4S.C33H41N9O3S/c1-11-12-13-14-15-16-17-18-19-20-21-22-23-24-27-59-38-26-25-36(46(2,3)4)31-39(38)60-61(58)55-37-29-34(44-49-42-32-40(47(5,6)7)51-56(42)53-44)28-35(30-37)45-50-43-33-41(48(8,9)10)52-57(43)54-45;1-8-9-10-11-12-13-14-15-16-37(60-34-19-23-36(24-20-34)61(58,59)35-21-17-33(56)18-22-35)44(57)47-32-26-30(42-48-40-28-38(45(2,3)4)50-54(40)52-42)25-31(27-32)43-49-41-29-39(46(5,6)7)51-55(41)53-43;1-11-12-13-14-15-16-17-18-19-20-21-22-23-24-27-54-37-26-25-34(43(2,3)4)30-38(37)55-56(53)50-36-29-33(28-35(31-36)46-42(52)45(8,9)10)41-47-40-32-39(44(5,6)7)48-51(40)49-41;1-20-10-11-25(21(2)14-20)45-13-9-12-34-46(43,44)24-16-22(30-35-28-18-26(32(3,4)5)37-41(28)39-30)15-23(17-24)31-36-29-19-27(33(6,7)8)38-42(29)40-31/h25-26,28-33,51-52,55H,11-24,27H2,1-10H3;17-29,37,50-51,56H,8-16H2,1-7H3,(H,47,57);25-26,28-32,48,50H,11-24,27H2,1-10H3,(H,46,52);10-11,14-19,34,37-38H,9,12-13H2,1-8H3
InChIKeyYUCQVFDOTWEOPS-UHFFFAOYSA-N
MW3137.29 g/mol
LogP40.35
Rot. Bonds70

About 3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide

3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide (PubChem CID 54482666) has the molecular formula C172H239N33O15S4 and a molecular weight of 3137.29 g/mol. Its IUPAC name is 3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide.

Molecular Properties

Compound Name3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide
PubChem CID54482666
Molecular FormulaC172H239N33O15S4
Molecular Weight3137.29 g/mol
Exact Mass3134.78
IUPAC Name3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide
SMILESCCCCCCCCCCC(Oc1ccc(S(=O)(=O)c2ccc(O)cc2)cc1)C(=O)Nc1cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)c1.CCCCCCCCCCCCCCCCOc1ccc(C(C)(C)C)cc1OS(=O)Nc1cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)c1.CCCCCCCCCCCCCCCCOc1ccc(C(C)(C)C)cc1OS(=O)Nc1cc(NC(=O)C(C)(C)C)cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)c1.Cc1ccc(OCCCNS(=O)(=O)c2cc(-c3nc4cc(C(C)(C)C)[nH]n4n3)cc(-c3nc4cc(C(C)(C)C)[nH]n4n3)c2)c(C)c1
InChIInChI=1S/C48H71N9O3S.C46H57N9O5S.C45H70N6O4S.C33H41N9O3S/c1-11-12-13-14-15-16-17-18-19-20-21-22-23-24-27-59-38-26-25-36(46(2,3)4)31-39(38)60-61(58)55-37-29-34(44-49-42-32-40(47(5,6)7)51-56(42)53-44)28-35(30-37)45-50-43-33-41(48(8,9)10)52-57(43)54-45;1-8-9-10-11-12-13-14-15-16-37(60-34-19-23-36(24-20-34)61(58,59)35-21-17-33(56)18-22-35)44(57)47-32-26-30(42-48-40-28-38(45(2,3)4)50-54(40)52-42)25-31(27-32)43-49-41-29-39(46(5,6)7)51-55(41)53-43;1-11-12-13-14-15-16-17-18-19-20-21-22-23-24-27-54-37-26-25-34(43(2,3)4)30-38(37)55-56(53)50-36-29-33(28-35(31-36)46-42(52)45(8,9)10)41-47-40-32-39(44(5,6)7)48-51(40)49-41;1-20-10-11-25(21(2)14-20)45-13-9-12-34-46(43,44)24-16-22(30-35-28-18-26(32(3,4)5)37-41(28)39-30)15-23(17-24)31-36-29-19-27(33(6,7)8)38-42(29)40-31/h25-26,28-33,51-52,55H,11-24,27H2,1-10H3;17-29,37,50-51,56H,8-16H2,1-7H3,(H,47,57);25-26,28-32,48,50H,11-24,27H2,1-10H3,(H,46,52);10-11,14-19,34,37-38H,9,12-13H2,1-8H3
InChIKeyYUCQVFDOTWEOPS-UHFFFAOYSA-N
XLogP40.35
TPSA594.18 Ų
H-Bond Donors13
H-Bond Acceptors36
Rotatable Bonds70
Heavy Atoms224
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003137.29
LogP ≤ 540.35
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1036

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide?
The IUPAC name of 3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide (CID 54482666) is 3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide.
What is the SMILES notation for 3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide?
The canonical SMILES for 3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide is CCCCCCCCCCC(Oc1ccc(S(=O)(=O)c2ccc(O)cc2)cc1)C(=O)Nc1cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)c1.CCCCCCCCCCCCCCCCOc1ccc(C(C)(C)C)cc1OS(=O)Nc1cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)c1.CCCCCCCCCCCCCCCCOc1ccc(C(C)(C)C)cc1OS(=O)Nc1cc(NC(=O)C(C)(C)C)cc(-c2nc3cc(C(C)(C)C)[nH]n3n2)c1.Cc1ccc(OCCCNS(=O)(=O)c2cc(-c3nc4cc(C(C)(C)C)[nH]n4n3)cc(-c3nc4cc(C(C)(C)C)[nH]n4n3)c2)c(C)c1.
What is the InChIKey of 3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide?
The InChIKey is YUCQVFDOTWEOPS-UHFFFAOYSA-N. The full InChI is InChI=1S/C48H71N9O3S.C46H57N9O5S.C45H70N6O4S.C33H41N9O3S/c1-11-12-13-14-15-16-17-18-19-20-21-22-23-24-27-59-38-26-25-36(46(2,3)4)31-39(38)60-61(58)55-37-29-34(44-49-42-32-40(47(5,6)7)51-56(42)53-44)28-35(30-37)45-50-43-33-41(48(8,9)10)52-57(43)54-45;1-8-9-10-11-12-13-14-15-16-37(60-34-19-23-36(24-20-34)61(58,59)35-21-17-33(56)18-22-35)44(57)47-32-26-30(42-48-40-28-38(45(2,3)4)50-54(40)52-42)25-31(27-32)43-49-41-29-39(46(5,6)7)51-55(41)53-43;1-11-12-13-14-15-16-17-18-19-20-21-22-23-24-27-54-37-26-25-34(43(2,3)4)30-38(37)55-56(53)50-36-29-33(28-35(31-36)46-42(52)45(8,9)10)41-47-40-32-39(44(5,6)7)48-51(40)49-41;1-20-10-11-25(21(2)14-20)45-13-9-12-34-46(43,44)24-16-22(30-35-28-18-26(32(3,4)5)37-41(28)39-30)15-23(17-24)31-36-29-19-27(33(6,7)8)38-42(29)40-31/h25-26,28-33,51-52,55H,11-24,27H2,1-10H3;17-29,37,50-51,56H,8-16H2,1-7H3,(H,47,57);25-26,28-32,48,50H,11-24,27H2,1-10H3,(H,46,52);10-11,14-19,34,37-38H,9,12-13H2,1-8H3.
What are the key properties of 3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide?
3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide has a molecular weight of 3137.29 g/mol, XLogP of 40.35, 70 rotatable bonds, 13 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)-N-[3-(2,4-dimethylphenoxy)propyl]benzenesulfonamide;N-[3,5-bis(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2-[4-(4-hydroxyphenyl)sulfonylphenoxy]dodecanamide;6-tert-butyl-2-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-5H-pyrazolo[1,5-b][1,2,4]triazole;N-[3-[(5-tert-butyl-2-hexadecoxyphenoxy)sulfinylamino]-5-(6-tert-butyl-5H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenyl]-2,2-dimethylpropanamide is sourced from PubChem (CID 54482666), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).